**ROLE SUMMARY** Pfizer’s U.S. Hospital Sterile Injectables business collectively comprises over 200 products spanning more than 10 therapeutic areas, representing the broadest portfolio of sterile injectable medicines in the United States with annual revenue of ~ $2B. Pfizer Hospital’s Ready-to-Use products represent an important and innovative segment of the Pfizer Hospital sterile injectables portfolio, and […]
